Skip to main content

Table 2 Multivariable analysis of in hospital mortality and orotracheal intubation in the complete cohort (n = 1170)

From: Outcome and death risk of diabetes patients with Covid-19 receiving pre-hospital and in-hospital metformin therapies

Characteristic

Mortality risk factors OR (CI 95%)

Orotracheal intubation risk factors OR (CI 95%)

Covariables included in the logistic analysis

Age

Diabetes Mellitus

Obesity

CKD

1.142 (1.03–1.18)

NS

NS

1.042 (1.02–1.06)

3.29 (1.99–5.47)

2.158 (1.13–4.11)

3.1 (1.22–7.82)

Age and gender and all comorbidities

Prisma

NEWS/PEWS

CLHO/HCQ

12.06 (1.31–110.81)

1.34 (1.06–1.7)

10.46 91.23–88.52)

NS

1.34 (1.06–1.69)

10.16 (1.2–86.02)

Orotracheal intubation, prona, prisma, NEWS/PEWS

Vasoactive drug and CLHO/HCQ

  1. NS, not significant; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease; NEWS/PEWS, National Early Warning Score/Pediatric Early Warning Score; Prisma, prisma hemodialysis machine; Prona, prone position; CLHO/HCQ, Chloroquine /hydroxychloroquine